Global Ravicti Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Ravicti Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Ravicti is a medication used in the treatment of certain inborn urea cycle disorders. The medication works by preventing the harmful buildup of ammonia in the body.
Ravicti report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ravicti market is projected to reach US$ 556.5 million in 2029, increasing from US$ 325.7 million in 2022, with the CAGR of 6.8% during the period of 2024 to 2029. Demand from Hospital and Pharmacy are the major drivers for the industry.
The Ravicti market is driven by the increasing prevalence of urea cycle disorders (UCD), a group of rare genetic conditions affecting ammonia metabolism. Ravicti, a medication containing glycerol phenylbutyrate, is used to manage UCD by reducing ammonia levels in the blood. The drug's efficacy and safety profile have contributed to its growing adoption among UCD patients. Moreover, advancements in diagnostic methods and increased awareness of UCD have led to early diagnosis and treatment initiation, further propelling market growth. However, challenges include the high cost of the medication, potential side effects, and the need for continued research to optimize treatment outcomes and expand its use in various populations. Overcoming these challenges and providing access to affordable and effective treatments will be vital for the sustained growth of the Ravicti market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ravicti market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Horizon Pharma
Segment by Type
25ml
50ml
Hospital
Pharmacy
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Ravicti market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ravicti, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ravicti industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Ravicti in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ravicti introduction, etc. Ravicti Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Ravicti market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Ravicti report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ravicti market is projected to reach US$ 556.5 million in 2029, increasing from US$ 325.7 million in 2022, with the CAGR of 6.8% during the period of 2024 to 2029. Demand from Hospital and Pharmacy are the major drivers for the industry.
The Ravicti market is driven by the increasing prevalence of urea cycle disorders (UCD), a group of rare genetic conditions affecting ammonia metabolism. Ravicti, a medication containing glycerol phenylbutyrate, is used to manage UCD by reducing ammonia levels in the blood. The drug's efficacy and safety profile have contributed to its growing adoption among UCD patients. Moreover, advancements in diagnostic methods and increased awareness of UCD have led to early diagnosis and treatment initiation, further propelling market growth. However, challenges include the high cost of the medication, potential side effects, and the need for continued research to optimize treatment outcomes and expand its use in various populations. Overcoming these challenges and providing access to affordable and effective treatments will be vital for the sustained growth of the Ravicti market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ravicti market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Horizon Pharma
Segment by Type
25ml
50ml
Segment by Application
Hospital
Pharmacy
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Ravicti market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ravicti, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ravicti industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Ravicti in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ravicti introduction, etc. Ravicti Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Ravicti market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices